Preventable Vaccines Market By Type (Pediatric Preventable Vaccines and Adult Preventable Vaccines) and Application (Virus Diseases and Bacterial Diseases) - Global Industry Analysis And Forecast To 2025

Industry Outlook

Preventable Vaccines are those, which are used to avoid or prevent any disease from occurring. Some of the vaccine preventable serious disorders are; hepatitis B, influenza, pertussis, poliomyelitis, diphtheria, meningitis, measles, mumps, yellow fever, neonatal tetanus, etc. Increase in immunization programs by government is seen is various economies to suppress serious disorders. Factors for the increasing use of Preventable Vaccines are; development in biomedical field, technical development in the manufacturing, rising occurrence of vaccine preventable disorders, etc. Therefore, the Preventable Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global Preventable Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Preventable Vaccines Market is based on segment, by Type the market is segmented into Pediatric Preventable Vaccines and Adult Preventable Vaccines; and by Application the market is segmented into Virus Diseases and Bacterial Diseases.


Preventable Vaccines Market, By Type

Pediatric Preventable Vaccines
Adult Preventable Vaccines

Preventable Vaccines Market, By Application

Virus Diseases
Bacterial Diseases


Regional Insights

On a global front, the Preventable Vaccines Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Preventable Vaccines Market, By Region




North America


U.S.
Canada
Mexico

Europe


Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America


Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA


Competitive Analysis

The leading players in the market are Sanofi, GlaxoSmithKline, Mitsubishi Tanabe Pharma, Merck, LG Life Sciences, Novartis, AstraZeneca, Emergent Biosciences Inc., Pfizer, Bharat Biotech, Abbott, Bavarian Nordic and Roche. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


Sanofi
GlaxoSmithKline
Mitsubishi Tanabe Pharma
Merck
LG Life Sciences
Novartis
AstraZeneca
Emergent Biosciences Inc.
Pfizer
Bharat Biotech
Abbott
Bavarian Nordic
Roche


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?